Education
About Us
Working with TipRanks
Follow Us
Avram Friedman Insider Profile
4 Followers
Avram Friedman, Ten Percent Owner at Chelsea Therapeutics, holds 2.00M shares in Chelsea Therapeutics (Ticker: CHTP), holds ― shares in ARKO Corp (Ticker: ARKO), holds 20.00K shares in ARKO Petroleum Corp. Class A (Ticker: APC). Most recently, Avram Friedman ― shares of Chelsea Therapeutics on ― for an estimated value of ―.
Avram Friedman Chelsea Therapeutics (CHTP)Ten Percent Owner
Chelsea Therapeutics (CHTP)
Ten Percent Owner
Not Ranked
Avram Friedman has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Avram Friedman holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Avram Friedman
Avram Friedman's Trading History
Chelsea Therapeutics
―
―
―
―
ARKO Corp
―
Director
―
―
ARKO Petroleum Corp. Class A
Feb 18, 2026
Director
Informative Buy
360.00K
$366.70K
List of latest transactions for each holding click on a transaction to see Avram Friedman's performance on stock
You May Also Like
Avram Friedman insider profile FAQ
What is the percentage of profitable transactions made by Avram Friedman?
The percentage of profitable transactions made by Avram Friedman is ―.
What is the average return per transaction made by Avram Friedman?
The average return per transaction made by Avram Friedman is ―.
What stocks does Avram Friedman hold?
Avram Friedman holds: CHTP, ARKO, APC stocks.
What was Avram Friedman’s latest transaction?
Avram Friedman latest transaction was an Uninformative Buy of ―.
What was Avram Friedman's most profitable transaction?
Avram Friedman’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Avram Friedman's role in Chelsea Therapeutics?
Avram Friedman's role in Chelsea Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.